Search Results

There are 11541 results for: content related to: Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer

  1. 2013 AAPM Annual Meeting Program

    Medical Physics

    Volume 40, Issue 6, June 2013, Pages: 82–553,

    Version of Record online : 6 JUN 2013, DOI: 10.1002/j.2473-4209.2013.tb00215.x

  2. You have free access to this content
    Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer

    British Journal of Clinical Pharmacology

    Volume 69, Issue 5, May 2010, Pages: 465–474, Stijn L. W. Koolen, Roos L. Oostendorp, Jos H. Beijnen, Jan H. M. Schellens and Alwin D. R. Huitema

    Version of Record online : 28 JAN 2010, DOI: 10.1111/j.1365-2125.2010.03621.x

  3. You have full text access to this OnlineOpen article
    Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose

    Cancer Science

    Volume 106, Issue 5, May 2015, Pages: 497–504, Hirotsugu Kenmotsu and Yusuke Tanigawara

    Version of Record online : 25 MAR 2015, DOI: 10.1111/cas.12647

  4. Docetaxel-Associated Epiphora

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 26, Issue 6, June 2006, Pages: 853–867, Dr. Polly E. Kintzel, Dr. Laura B. Michaud and Dr. Marianne K. Lange

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.26.6.853

  5. Docetaxel increases antitumor efficacy of oncolytic prostate-restricted replicative adenovirus by enhancing cell killing and virus distribution

    The Journal of Gene Medicine

    Volume 12, Issue 6, June 2010, Pages: 516–527, Xiong Li, Youhong Liu, Yong Tang, Phipps Roger, Meei-Huey Jeng and Chinghai Kao

    Version of Record online : 17 MAY 2010, DOI: 10.1002/jgm.1462

  6. You have free access to this content
    Neoadjuvant systemic therapy for urological malignancies

    BJU International

    Volume 106, Issue 1, July 2010, Pages: 6–22, Guru Sonpavde and Cora N. Sternberg

    Version of Record online : 7 JUN 2010, DOI: 10.1111/j.1464-410X.2010.09425.x

  7. You have free access to this content
    Rational indication for docetaxel rechallenge in metastatic castration-resistant prostate cancer

    BJU International

    Volume 110, Issue 11b, December 2012, Pages: E635–E640, Matthias M. Heck, Mark Thalgott, Margitta Retz, Petra Wolf, Tobias Maurer, Roman Nawroth, Georgios Hatzichristodoulou, Jürgen E. Gschwend and Hubert Kübler

    Version of Record online : 13 AUG 2012, DOI: 10.1111/j.1464-410X.2012.11364.x

  8. 55th ANNUAL MEETING AND EXHIBITION

    Medical Physics

    Volume 40, Issue 6, June 2013, Pages: 1–579,

    Version of Record online : 6 JUN 2013, DOI: 10.1002/j.2473-4209.2013.tb00217.x

  9. Docetaxel Nanotechnology in Anticancer Therapy

    ChemMedChem

    Volume 7, Issue 6, June 2012, Pages: 952–972, Pengxiang Zhao and Didier Astruc

    Version of Record online : 19 APR 2012, DOI: 10.1002/cmdc.201200052

  10. You have free access to this content
    Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high-risk, locally advanced prostate cancer

    Cancer

    Volume 115, Issue 4, 15 February 2009, Pages: 784–791, Jacqueline Vuky, Christopher Porter, Christina Isacson, Matthew Vaughan, Paul Kozlowski, Vincent Picozzi and John Corman

    Version of Record online : 6 JAN 2009, DOI: 10.1002/cncr.24092

  11. You have free access to this content
    Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors

    International Journal of Cancer

    Volume 118, Issue 2, 15 January 2006, Pages: 396–404, Madhu Sudhan Shaik, Abhijit Chatterjee, Tanise Jackson and Mandip Singh

    Version of Record online : 28 JUL 2005, DOI: 10.1002/ijc.21325

  12. You have free access to this content
    Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer

    Cancer

    Volume 110, Issue 12, 15 December 2007, Pages: 2628–2639, Guru Sonpavde, Kim N. Chi, Thomas Powles, Christopher J. Sweeney, Noah Hahn, Thomas E. Hutson, Matthew D. Galsky, William R. Berry and Dov Kadmon

    Version of Record online : 16 OCT 2007, DOI: 10.1002/cncr.23085

  13. You have free access to this content
    Phase I study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancer

    BJU International

    Volume 110, Issue 11b, December 2012, Pages: E721–E726, Ronald C. Chen, Julian G. Rosenman, Leroy G. Hoffman, Wing-Keung Chiu, Andrew Z. Wang, Raj S. Pruthi, Eric M. Wallen, Jeffrey M. Crane, William Y. Kim, W. Kimryn Rathmell, Paul A. Godley and Young E. Whang

    Version of Record online : 27 SEP 2012, DOI: 10.1111/j.1464-410X.2012.11536.x

  14. The use of LC-MS to identify differentially expressed proteins in docetaxel-resistant prostate cancer cell lines

    PROTEOMICS

    Volume 12, Issue 13, July 2012, Pages: 2115–2126, Kathleen O'Connell, Maria Prencipe, Amanda O'Neill, Claire Corcoran, Sweta Rani, Michael Henry, Paul Dowling, Paula Meleady, Lorraine O'Driscoll, William Watson and Robert O'Connor

    Version of Record online : 17 JUL 2012, DOI: 10.1002/pmic.201100489

  15. You have free access to this content
    Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients

    British Journal of Clinical Pharmacology

    Volume 73, Issue 4, April 2012, Pages: 606–618, Sin Chi Chew, Edwin Sandanaraj, Onkar Singh, Xiangai Chen, Eng Huat Tan, Wan Teck Lim, Edmund J. D. Lee and Balram Chowbay

    Version of Record online : 12 MAR 2012, DOI: 10.1111/j.1365-2125.2011.04123.x

  16. You have free access to this content
    The Royal Australian and New Zealand College of Radiologists 64th Annual Scientific Meeting

    Journal of Medical Imaging and Radiation Oncology

    Volume 57, Issue S1, October 2013, Pages: 120–176,

    Version of Record online : 9 OCT 2013, DOI: 10.1111/1754-9485.12121

  17. You have free access to this content
    Dasatinib combined with docetaxel for castration-resistant prostate cancer

    Cancer

    Volume 118, Issue 1, 1 January 2012, Pages: 63–71, John C. Araujo, Paul Mathew, Andrew J. Armstrong, Edward L. Braud, Edwin Posadas, Mathew Lonberg, Gary E. Gallick, Géralyn C. Trudel, Prashni Paliwal, Shruti Agrawal and Christopher J. Logothetis

    Version of Record online : 4 MAR 2011, DOI: 10.1002/cncr.26204

  18. Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer

    The Prostate

    Volume 75, Issue 15, November 1, 2015, Pages: 1814–1820, Benjamin L. Maughan, Xian C. Xhou, Daniel L. Suzman, Rosa Nadal, Sunakshi Bassi, Michael T. Schweizer and Emmanuel S. Antonarakis

    Version of Record online : 26 AUG 2015, DOI: 10.1002/pros.23064

  19. You have full text access to this OnlineOpen article
    Safety and efficacy of single-agent docetaxel (Taxotere) administered weekly in non-small cell lung carcinoma patients in Korea: An observational study

    Thoracic Cancer

    Volume 7, Issue 2, March 2016, Pages: 207–214, Sun Min Lim, Byeong Bae Park, Keun-Chil Park, Hoon-Kyo Kim, Jong Seok Lee, Sung Hwa Bae, Seung-Sei Lee, Jin-Hyoung Kang, Se-Hoon Park, Gyeong-Won Lee, Hyo-Rac Lee, Jae Hong Seo, Yong Tae Kim, Sung Hyun Yang and Joo-Hang Kim

    Version of Record online : 1 NOV 2015, DOI: 10.1111/1759-7714.12315

  20. You have free access to this content
    The effect of Echinacea purpurea on the pharmacokinetics of docetaxel

    British Journal of Clinical Pharmacology

    Volume 76, Issue 3, September 2013, Pages: 467–474, Andrew K. L. Goey, Irma Meijerman, Hilde Rosing, Jacobus A. Burgers, Marja Mergui-Roelvink, Marianne Keessen, Serena Marchetti, Jos H. Beijnen and Jan H. M. Schellens

    Version of Record online : 20 AUG 2013, DOI: 10.1111/bcp.12159